These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 874368

  • 1. Biological behavior of higher molecular weight products of fibrinolysis.
    Chang ML, Bang NU.
    J Lab Clin Med; 1977 Jul; 90(1):216-26. PubMed ID: 874368
    [Abstract] [Full Text] [Related]

  • 2. [Differentiation of fibrinolysis and fibrinogenolysis by analysis of FDP fragments].
    Okumura N, Furuwatari C, Ishikawa S, Furihata K, Katsuyama T, Kanai M, Nakahata T, Saitoh H.
    Rinsho Byori; 1992 Jul; 40(7):789-94. PubMed ID: 1507499
    [Abstract] [Full Text] [Related]

  • 3. [Clinical significance of a new fibrinogen/fibrin degradation products(FDP) test using plasma samples for the diagnosis of fibrinogenolysis and fibrinolysis].
    Imoto K, Yasumuro Y, Taki M, Suzuki N, Tanabe H, Ichikawa Y.
    Rinsho Byori; 2001 Mar; 49(3):283-9. PubMed ID: 11307330
    [Abstract] [Full Text] [Related]

  • 4. [The role of DL and DH degradation products in the reactions of the plasmin hydrolysis of fibrinogen and fibrin].
    Rozenfel'd MA, Leonova VB, Khavkina LS.
    Izv Akad Nauk SSSR Biol; 1991 Mar; (3):334-42. PubMed ID: 1835465
    [Abstract] [Full Text] [Related]

  • 5. The effect of homologous thrombin and fibrinogen degradation products on fibrinogen synthesis in rabbits.
    Kessler CM, Bell WR.
    J Lab Clin Med; 1979 May; 93(5):768-82. PubMed ID: 219123
    [Abstract] [Full Text] [Related]

  • 6. [Analysis of cross-linked fibrin and fibrinogen degradation products with SDS-PAGE and immunoblot].
    Okumura N, Kagiya H, Kumagai T, Kameko M, Tozuka M, Saito H, Katsuyama T, Kanai M.
    Rinsho Byori; 1990 Feb; 38(2):201-7. PubMed ID: 2329722
    [Abstract] [Full Text] [Related]

  • 7. [Studies on the fragments of FDP in 3 patients with DIC associated with acute promyelocytic leukemia].
    Okumura N, Furuwatari C, Ishikawa S, Furihata K, Katsuyama T, Kanai M, Nakahata T, Saitoh H.
    Rinsho Byori; 1993 Jun; 41(6):719-25. PubMed ID: 8361040
    [Abstract] [Full Text] [Related]

  • 8. Catabolism of purified rat fibrin(ogen) plasmin degradation products in rats.
    Nieuwenhuizen W, Emeis JJ, Vermond A.
    Thromb Haemost; 1982 Aug 24; 48(1):59-61. PubMed ID: 7135343
    [Abstract] [Full Text] [Related]

  • 9. The roles of renal catabolism and uremia in modifying the clearance of fibrinogen and its degradative fragments D and E.
    Iio A, Rutherford WE, Wochner RD, Spilberg I, Sherman LA.
    J Lab Clin Med; 1976 Jun 24; 87(6):934-46. PubMed ID: 932524
    [Abstract] [Full Text] [Related]

  • 10. Sustained fibrinolysis after administration of t-PA despite its short half-life in the circulation.
    Eisenberg PR, Sherman LA, Tiefenbrunn AJ, Ludbrook PA, Sobel BE, Jaffe AS.
    Thromb Haemost; 1987 Feb 03; 57(1):35-40. PubMed ID: 3109058
    [Abstract] [Full Text] [Related]

  • 11. Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.
    Weitz JI, Leslie B, Ginsberg J.
    J Clin Invest; 1991 Mar 03; 87(3):1082-90. PubMed ID: 1900308
    [Abstract] [Full Text] [Related]

  • 12. Effect of crosslinking on the structure of solubilized fibrin degradation products in whole plasma.
    Carroll RC, Lockhart MS, Taylor FB.
    J Lab Clin Med; 1984 May 03; 103(5):695-703. PubMed ID: 6232329
    [Abstract] [Full Text] [Related]

  • 13. A simple rapid method for isolating soluble fibrin complexes from fibrinogen by treatment with thrombin and t-AMCHA.
    Hayashi S, Yamada K.
    Thromb Haemost; 1980 Feb 29; 42(5):1388-97. PubMed ID: 6154323
    [Abstract] [Full Text] [Related]

  • 14. [Measurements of plasmin-alpha 2 plasmin inhibitor complex and FDP.D dimer levels in the fibrinolytic therapy of acute pulmonary thromboembolism].
    Yamasawa F, Hasegawa N, Asano K, Sayama K, Fujita H, Urano T, Aoki T, Ishizaka A, Kanazawa M, Kawashiro T.
    Kokyu To Junkan; 1992 Jul 29; 40(7):685-90. PubMed ID: 1387724
    [Abstract] [Full Text] [Related]

  • 15. Electrophoretic demonstration of high molecular weight fibrin degradation products persisting in chronic subdural hematomas.
    Toyosawa M, Kashiwagi S, Pei W, Fujisawa H, Ito H, Nakamura K.
    Electrophoresis; 1997 Jan 29; 18(1):118-21. PubMed ID: 9059832
    [Abstract] [Full Text] [Related]

  • 16. Separation of fibrinogen degradation products (FDP) by means of adsorption to insolubilized fibrinmonomer (FM-ag).
    Heene DL, Matthias FR, Wegrzynowicz Z, Hocke G.
    Thromb Haemost; 1979 Jun 30; 41(4):677-86. PubMed ID: 483241
    [Abstract] [Full Text] [Related]

  • 17. Fibrinogen catabolism within the procoagulant VX-2 tumor of rabbit lung in vivo: Effluxing fibrin(ogen) fragments contain antiangiogenic activity.
    Hatton MW, Southward SM, Legault KJ, Ross BL, Clarke BJ, Bajzar L, Blajchman MA, Singh G, Richardson M.
    J Lab Clin Med; 2004 Apr 30; 143(4):241-54. PubMed ID: 15085083
    [Abstract] [Full Text] [Related]

  • 18. Fibrinogen/fibrin degradation products (FDP/fdp). Characterization, anticoagulant activity, and influence on laboratory assays.
    Arnesen H.
    J Oslo City Hosp; 1977 Jun 30; 27(6):69-80. PubMed ID: 142131
    [No Abstract] [Full Text] [Related]

  • 19. Plasma cross-linked fibrin degradation product (XLFbDP) assays in an in vivo model of fibrinolysis.
    Rowbotham BJ, Whitaker AN, Masci PP.
    Blood Coagul Fibrinolysis; 1990 Dec 30; 1(6):653-61. PubMed ID: 2133245
    [Abstract] [Full Text] [Related]

  • 20. [Studies on the fragments of FDP in 4 patients with DIC].
    Okumura N, Furuwatari C, Ishikawa S, Furihata K, Katsuyama T, Kanai M, Nakahata T, Saitoh H.
    Rinsho Byori; 1992 Oct 30; 40(10):1089-95. PubMed ID: 1307614
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.